Ipca Laboratories reported a 31% rise in December quarter profit, supported by double-digit growth in Indian formulations and exports, while margins improved year-on-year. Shares traded higher following the announcement.
Ipca Laboratories reported a 31% rise in December quarter profit, supported by double-digit growth in Indian formulations and exports, while margins improved year-on-year. Shares traded higher following the announcement.